Analysis by Dr. Joseph Mercola Fact Checked December 06, 2022
STORY AT-A-GLANCE
· “Vaccine equity” remains
high on the global cabal’s list of priorities, even though real-world evidence
shows the COVID shots have done more harm than good
· Africa, where fewer than 6%
of people have received the COVID jab, have maintained an extremely low COVID-19
death rate throughout the last three years, likely because they didn’t have
equal access to experimental COVID injections
· While wholly ignoring the
African experience, U.S. media are now trying to scare people into taking
additional shots for fall by warning of an incoming “tripledemic” of COVID, flu
and respiratory syncytial virus (RSV)
· The tripledemic narrative
is scientifically implausible. Respiratory viruses tend to interfere with each
other’s spread, such that one typically ends up dominating
· Pfizer’s and Moderna’s
pediatric trials both found RSV infection was more prevalent among children who
got their COVID jabs than those who didn’t
The globalist cabal that invented and drove the make-believe COVID narrative is facing growing problems, as holes in the logic just keep getting larger over time. Case in point: The irrational promotion of vaccine equity.1
According to
the World Health Organization and other globalist strongholds, the Western
world must sponsor vaccine deliveries to developing nations to make sure
everyone has an equal chance at survival.2
The problem is
that developing nations with the lowest COVID jab uptakes have fared no worse,
and in some cases far better, than developing countries that greedily
"hoarded" shots and boosters for themselves.
The African Conundrum
According to
early predictions, Africa would be decimated by COVID for lack of shots,3 yet the COVID death
toll in Africa has remained consistently lower than anywhere else over the past
three years. Everyone feigns surprise. No one can figure out why. In August
2020, Science magazine reported:4
"Antibody
studies suggest large numbers of infections have occurred but the death toll
remains low ... After testing more than 3,000 blood donors, Uyoga and
colleagues estimated in a preprint5 ... that
one in 20 Kenyans aged 15 to 64 — or 1.6 million people — has antibodies to
SARS-CoV-2, an indication of past infection.
That would put
Kenya on a par with Spain in mid-May6 when that
country was descending from its coronavirus peak and had 27,000 official
COVID-19 deaths. Kenya's official toll stood at 100 when the study ended. And
Kenya's hospitals are not reporting huge numbers of people with COVID-19
symptoms."
The situation
was still the same in November 2021, when media reported that Africa, where
fewer than 6% of people had received a COVID shot, was among the countries
least affected by COVID. Researchers theorized that "lower rates of
urbanization, genetic reasons or exposure to other diseases may have spared the
continent the more lethal effects of the virus."7
No one in
mainstream media has been willing to address any of the towering elephants in
the room, which include the fact that the COVID shots don't prevent cases or
deaths, that natural immunity is superior, and that COVID-19 was never as
lethal a threat as they said it was. Africa gives us real-world evidence of
these facts, yet the globalist cabal still insist that "vaccine
equity" is an imperative goal.
Even though
places like Africa didn't have adequate access to COVID shots, and even though
they fared just as well or better than the Western world where COVID shot
uptake was high, the cabal insist we still need to make sure that, next time,
Africa will get the same kind of injection coverage as the rest of the world.
This makes no
sense, especially when you consider that the majority of COVID deaths in the
U.S. and elsewhere now occur among those who got the COVID jabs.8
But, judging by
the last three years, they're not even going to try to make sense of it. Instead,
they'll simply continue to avoid talking about success stories like Africa,
where COVID ended up having little impact — probably due to ultra-low injection
rates — and when they do talk about it, it'll continue to be veiled as a
medical mystery.
What's Really Behind the
Pressing Need for Vaccine Equity?
Responding to
vaccine equity calls from the World Health Organization, Pfizer and Moderna
both plan to manufacture COVID shots in Africa "to more efficiently
address vaccination needs on the continent."9
But what's
really behind this push for global vaccine equity? If you ask me, it's because
vaccines are an integral part of the totalitarian biosecurity state being set
up to control the world's population using vaccine passports and digital identity.
There's also
compelling evidence to suggest vaccines will be used to drive a
Malthusian-based depopulation agenda. Naturally, the eugenicists behind COVID
and the COVID shots would not want developing nations like Africa to escape
this global dragnet.
New Wave of Fear-Porn to
Drive Vaccination Uptake
While wholly
ignoring the African experience, U.S. media are now trying to scare people into
taking additional shots for fall by warning of an incoming "tripledemic"
of COVID, flu and respiratory syncytial virus (RSV). As fear of COVID variants
is wearing off, perhaps fear of three simultaneous viral threats will re-stoke
the flames of paranoia? As reported by STAT News November 22, 2022:10
"A viral
hurricane is making landfall on health care systems battered by three pandemic
years. With the official start of winter still weeks away, pediatric hospitals
are facing crushing caseloads of children sick with RSV and other viral
illnesses.
Schools that
promised a 'return to normal' now report widespread absences and even closures
from RSV and flu in many parts of the country, contributing to parents missing
work in record numbers.
With this
year's flu season beginning some six weeks early, the CDC has already declared
a flu epidemic as hospitalizations for influenza soared to the highest point in
more than a decade. A storm of these proportions should demand not only crisis
clinical measures, but also community prevention efforts."
In other words,
expect renewed calls for masks, social distancing, lockdowns and the canceling
of holiday get-togethers where people might share wrongthink and love for
humanity in equal measure. And, of course, expect massive COVID booster and flu
shot campaigns, and shaming of those who decide to abstain.
The Problem With the
Tripledemic Narrative
The problem
with the tripledemic narrative is that it's scientifically implausible. Those
with little or no understanding of how viruses work might fall into the trap of
thinking that if one virus is bad, two or three circulating at the same time
will be far worse. But it's not that linear in real life.
In a November
18, 2022, Science magazine article, Jon Cohen explained why a simultaneous
tripledemic is unlikely:11
"Triple
threat. Tripledemic. A viral perfect storm. These frightening phrases have
dominated recent headlines as some health officials, clinicians, and scientists
forecast that SARS-CoV-2, influenza, and respiratory syncytial virus (RSV)
could surge at the same time in Northern Hemisphere locales that have relaxed
masking, social distancing, and other COVID-19 precautions.
But a growing
body of epidemiological and laboratory evidence offers some reassurance:
SARS-CoV-2 and other respiratory viruses often 'interfere' with each other.
Although waves
of each virus may stress emergency rooms and intensive care units, the small
clique of researchers who study these viral collisions say there is little
chance the trio will peak together and collectively crash hospital systems the
way COVID-19 did at the pandemic's start.
'Flu and other
respiratory viruses and SARS-CoV-2 just don't get along very well together,'
says virologist Richard Webby, an influenza researcher at St. Jude Children's
Research Hospital. 'It's unlikely that they will circulate widely at the same
time.'
'One virus
tends to bully the others,' adds epidemiologist Ben Cowling at the University
of Hong Kong School of Public Health. During the surge of the highly
transmissible Omicron variant of SARS-CoV-2 in Hong Kong in March, Cowling
found that other respiratory viruses 'disappeared … and they came back again in
April' ...
Recent advances
in technology ... make it easier to detect infections in people and study how
multiple viruses behave ... Increasingly, researchers are fingering a cause:
chemical messengers that infected people produce called, fittingly,
interferons.
When a
respiratory virus sweeps through a community, interferons can broadly raise the
body's defenses and temporarily erect a population wide immune barrier against
subsequent viruses that target the respiratory system.
'Basically,
every virus triggers the interferon response to some extent, and every virus is
susceptible to it,' says immunologist Ellen Foxman at Yale University, who has
been exploring interference between SARS-CoV-2 and other viruses in a
laboratory model of the human airway.
Rhinoviruses,
which cause common colds, can trip up influenza A (the most prevalent flu
virus). RSV can bump rhinoviruses and human metapneumoviruses. Influenza A can
thwart its distant cousin influenza B.
'There are a
lot of major health implications from viral interference,' says Guy Boivin, a
virologist at Laval University who co-authored a review12 on viral
interference earlier this year ...
Unlike other
immune responses — antibodies, for example — that target specific pathogens an
animal has seen in the past, this nonspecific, rapid response [of interferon]
is part of what's known as the immune system's innate arm."
COVID Shots Likely Responsible
for Soaring RSV Rates in Kids
In related
news, evidence suggests RSV didn't soar out of season for no reason. In fact,
it appears to be a result of the pediatric COVID jab campaign. Documents from
Pfizer's and Moderna's pediatric trials submitted to the U.S. Food and Drug
Administration reveal the injected group suffered higher rates of RSV,
specifically, compared to controls.
Moderna's trial
involving 2- to 5-year-olds found RSV was four times more prevalent among
children in the jabbed group compared to the unjabbed.
Moderna's trial
involving 2- to 5-year-olds found RSV was four times more prevalent among
children in the jabbed group compared to the unjabbed:13
"Within 28
days after vaccination, some respiratory tract-related infections were reported
with greater frequency in the mRNA-1273 group than in the placebo group. Events
of pneumonia were reported by 0.3% and 0% of mRNA-1273 and placebo recipients,
respectively. Respiratory syncytial virus (RSV) was reported by 0.4% and
<0.1% of mRNA-1273 and placebo recipients, respectively."
The same
pattern was found in the 6- to 11-year-old trial, where RSV affected 0.3% of
those who got the jab, and zero percent among controls. Children who got the
jab were also more likely to contract some kind of upper respiratory tract
infection (3.9% compared to 2.5%).
Pfizer's
pediatric trial had similar results. Among 6-month-olds to 4-year-olds, RSV
bronchiolitis was reported in five participants, compared to three in the
control group. Is the U.S. Centers for Disease Control investigating this
pattern? We'll see.
The Informed
Consent Action Network (ICAN) has sent a letter to CDC director Dr. Rochelle
Walensky, requesting data on how many of the children with positive RSV tests
had received a COVID shot prior to their diagnosis.14
Take Control of Your
Family's Health This Winter Season
While
influenza, RSV and COVID can be problematic and dangerous for certain high-risk
individuals, the overall risks associated with them are negligible for most.
Just think back in your life — how many times have you had a cold or flu? How
many people do you know who died from a cold or flu?
At this point,
the vast majority of people have also had COVID, and are here to attest to its
nonlethality. Unfortunately, those who have gotten several COVID shots are now
in the high-risk category and may in fact experience more severe COVID
infection. For the unjabbed, the latest variants pose exceptionally low risk.
They may also be more susceptible to other respiratory infections. Among children, this includes RSV.
Keeping your
and your children's immune system strong is the best way to protect your family
this fall and winter, and there are many effective ways to do that. Here's a
short-list of some of the most important ones. For more details, follow the
hyperlinks provided.
•Optimize your vitamin D level — Higher levels of
vitamin D have been shown to decrease your risk of developing a severe case of,
and dying from, COVID-19. Vitamin D supplementation has also been shown to
reduce your risk of colds15 and influenza,16, 17 as it boosts your
innate immunity.
•Nebulized peroxide — Start at the very
first sign of any respiratory infection, preferably on the first day. The
longer you wait the less effective it will be, which is why you need to have
the nebulizer and solution locked and loaded and ready to use the moment you
notice the first symptom.
•Time-restricted eating (TRE) and
intermittent fasting — Both have been linked to less severe COVID
infection.
•Immune-boosting nutraceuticals such as vitamin C,
quercetin with zinc and N-acetylcysteine (NAC) — Zinc is a potent
broad-spectrum antiviral and quercetin helps transport it into the cell, where
it's needed. Vitamin C is also a premiere treatment for many
infections and helps boost overall immune function.
NAC, meanwhile, is a
precursor to reduced glutathione, which appears to play a crucial role in
COVID-19 specifically. Benefits of NAC include inhibiting expression of
proinflammatory cytokines, improving T cell response and inhibiting the
hypercoagulation that can result in stroke and/or blood clots that impair the
ability to exchange oxygen in the lungs.
Sources and References
·
1, 9 Time November 21, 2022
·
3, 7 AP November 19, 2021
·
6 The Lancet August 22, 2020;
396(10250): 535-544
·
8 Daily Mail November 24, 2022
·
10 STAT News November 22, 2022
·
11 Science November 18, 2022
·
12 Emerging Infectious Diseases February
2022; 28(2): 273-281
·
13, 14 Vigilant Fox Substack October 29,
2022
·
15 NIH Research Matters March 9, 2009
·
16 Nutrients April 2020; 12(4): 988
·
17 Canadian Family Physician June 2015; 61(6): 507
